Lv1
40 积分 2026-09-19 加入
Surufatinib combined camrelizumab as a valuable third-line rescue therapy for a patient with extensive-stage for small-cell lung cancer: a case report and literature review
8分钟前
已完结
Case Report: Immune-mediated acute liver failure induced by tislelizumab in a patient with advanced cervical cancer
1个月前
已完结
皖公网安备34019202002308
